الإحصائيات الأساسية
CIK | 1835378 |
SEC Filings
SEC Filings (Chronological Order)
February 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40048 INNOVID CORP. (Exact name of registrant as specified in its charte |
|
February 21, 2025 |
As filed with the Securities and Exchange Commission on February 21, 2025 As filed with the Securities and Exchange Commission on February 21, 2025 Registration No. |
|
February 14, 2025 |
February 14, 2025 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
February 14, 2025 |
As filed with the U.S. Securities and Exchange Commission on February 14, 2025 As filed with the U.S. Securities and Exchange Commission on February 14, 2025 Registration No. 333-262537 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-262537 UNDER THE SECURITIES ACT OF 1933 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 87-3769599 (State or other ju |
|
February 13, 2025 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 24, 2025, pursuant to the provisions of Rule 12d2-2 (a). |
|
February 13, 2025 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION INNOVID CORP. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INNOVID CORP. Innovid Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: The name of the Corporation is Innovid Corp. The date of filing of the original Certificate of Incorporation of the Corporation with the Secretary of State of the State of Delawar |
|
February 13, 2025 |
AMENDED AND RESTATED BY-LAWS INNOVID CORP. (the “Corporation”) ARTICLE I Exhibit 3.2 Final Form AMENDED AND RESTATED BY-LAWS OF INNOVID CORP. (the “Corporation”) ARTICLE I STOCKHOLDERS Section 1. Annual Meeting. The annual meeting of the stockholders of the Corporation (the “Stockholders”) shall be held either within or without the State of Delaware, at such place as the board of directors of the Corporation (the “Board of Directors”) may designate in the call or in a |
|
February 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
February 13, 2025 |
Exhibit 99.1 Mediaocean Completes Acquisition of Innovid – Creating the Premier Global Independent, Omnichannel Ad Tech Platform Innovid & Flashtalking Unite Under Mediaocean to Give Advertisers More Control, Choice, and Transparency NEW YORK – Feb. 13, 2025 – Mediaocean today announced the successful completion of its acquisition of Innovid, bringing together Innovid and Flashtalking to form an i |
|
February 13, 2025 |
Innovid Corp. 116 E 16th Street, 6th Floor New York, NY 10003 Exhibit 99.2 Innovid Corp. 116 E 16th Street, 6th Floor New York, NY 10003 February 13, 2025 Continental Stock Transfer & Trust Company 1 State Street, 30th Floor New York, NY 10004 Attention: Compliance Department Re: Notice of Merger of the Company (Warrant No. CUSIP-457679116) Dear Warrant Holder: Reference is made to (i) that certain Warrant Agreement, dated as of February 10, 2021 (the “Warra |
|
February 11, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 Innovid Corp. |
|
January 10, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
December 23, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D |
|
December 23, 2024 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) Innovid Corp. |
|
November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
November 21, 2024 |
CONTRIBUTION AND EXCHANGE AGREEMENT Exhibit 10.2 Execution Version CONTRIBUTION AND EXCHANGE AGREEMENT IN MAKING AN INVESTMENT DECISION, ROLLOVER STOCKHOLDER MUST RELY ON HIS, HER OR ITS OWN EXAMINATION OF TOPCO (AS DEFINED BELOW) AND ITS SUBSIDIARIES AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THE PARTNERSHIP UNITS TO BE ACQUIRED HEREUNDER HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE OR NON-U.S. SEC |
|
November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
November 21, 2024 |
DEFA14A 1 ea022209202-defa14ainnovid.htm SOLICITING MATERIAL UNDER RULE 14A-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, |
|
November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
November 21, 2024 |
Exhibit 10.1 Execution Version SUPPORT AGREEMENT SUPPORT AGREEMENT, dated as of November 21, 2024 (this “Support Agreement”), among Mediaocean LLC, a Delaware limited liability company (“Parent”), and the undersigned stockholder(s) of Innovid Corp., a Delaware corporation (the “Company”), listed on the signature pages hereto (each, a “Stockholder” and, collectively, the “Stockholders”). W I T N E |
|
November 21, 2024 |
Mediaocean to Acquire Innovid (NYSE:CTV) Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ |
|
November 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation |
|
November 21, 2024 |
Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ |
|
November 21, 2024 |
Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ |
|
November 21, 2024 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among MEDIAOCEAN LLC, IGNITE MERGER SUB, INC. and INNOVID CORP. Dated as of November 21, 2024 TABLE OF CONTENTS Page Article I DEFINITIONS & INTERPRETATIONS 2 1.1 Certain Definitions 2 1.2 Additional Definitions 16 1.3 Certain Interpretations 18 Article II THE MERGER 21 2.1 The Merger 21 2.2 The Effective Time 21 2.3 The Closing 21 |
|
November 21, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
November 14, 2024 |
CTV / Innovid Corp. / Phoenix Holdings Ltd. - SC 13G/A Passive Investment SC 13G/A 1 zk2432315.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Innovid Corp (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 457679108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropr |
|
November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 |
|
November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
November 12, 2024 |
Innovid Reports Q3 2024 Financial Results Exhibit 99.1 Innovid Reports Q3 2024 Financial Results ●Q3 2024 revenue increased 6% year-over-year to $38.3 million ●Q3 2024 net income improved year-over-year to $4.7 million and Adjusted EBITDA* increased 29% year-over-year to $8.4 million ●Adjusted EBITDA margin* increased to 22%, the ninth consecutive quarter of expansion ●Company announces board approval to implement stock repurchase program |
|
November 12, 2024 |
aration Agreement between Innovi Exhibit 10.1 SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE This SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Dave Helmreich (hereinafter “Executive”) (each a “party” and collectively, the “parties”). Executive’s employment with the Company end |
|
September 18, 2024 |
Mutual Separation Agreement between Innovid Corp. and David Helmreich dated September 15, 2024. Exhibit 10.1 1 SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE This SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Dave Helmreich (hereinafter “Executive”) (each a “party” and collectively, the “parties”). Executive’s employment with the Company e |
|
September 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or o |
|
September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm |
|
August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi |
|
August 6, 2024 |
EXHIBIT 10.1 SECOND LOAN MODIFICATION AGREEMENT This Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of June 26, 2024, by and among (a) SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (“Bank”) and (b) (i) INNOVID LLC, a Delaware limited liability company with its principal place of business located at 30 Irving Place 12th Floor New |
|
August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Inno |
|
August 6, 2024 |
Innovid Reports Q2 2024 Financial Results Exhibit 99.1 Innovid Reports Q2 2024 Financial Results ●Q2 2024 revenue increased 10% year-over-year to $38.0 million ●Q2 2024 net loss improved year-over-year to $10.5 million and Adjusted EBITDA* increased 29% year-over-year to $5.9 million ●Adjusted EBITDA margin increased to 15.5%, the eighth consecutive quarter of expansion ●CTV impression volume from ad serving and personalization increased |
|
August 1, 2024 |
CTV / Innovid Corp. / Phoenix Holdings Ltd. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Innovid Corp (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 457679108 (CUSIP Number) July 29, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
August 1, 2024 |
Exhibit 1 [Unofficial Translation] December 12, 2019 Powers of Signature in The Phoenix Holdings Ltd. |
|
June 25, 2024 |
CTV / Innovid Corp. / ION Crossover Partners Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp (Name of Issuer) Common Stock (Title of Class of Securities) 457679 10 8 (CUSIP Number) Mr. Anthony Reich, 13th Floor, Building E, 89 Medinat Hayehudim Street, Herzliya, Israel. +972-9-9703620 (Name, Address and Telephone Number of Person |
|
June 11, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commis |
|
May 28, 2024 |
CTV / Innovid Corp. / ION Crossover Partners Ltd - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp (Name of Issuer) Common Stock (Title of Class of Securities) 457679 10 8 (CUSIP Number) Mr. Anthony Reich, 13th Floor, Building E, 89 Medinat Hayehudim Street, Herzliya, Israel. +972-9-9703620 (Name, Address and Telephone Number of Person Aut |
|
May 24, 2024 |
CTV / Innovid Corp. / SEQUOIA CAPITAL ISRAEL IV, L.P. - SC 13G/A Passive Investment SC 13G/A 1 d675581dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, par value $0.0001 per share ( |
|
May 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi |
|
May 7, 2024 |
Innovid Reports Q1 2024 Financial Results Exhibit 99.1 Innovid Reports Q1 2024 Financial Results •Company exceeds both revenue and Adjusted EBITDA guidance for Q1 •Q1 revenue grew to $36.7 million, up 21% year-over-year •Q1 net loss improved year-over-year to $6.2 million and Adjusted EBITDA* improved to $4.4 million, representing a 12% Adjusted EBITDA margin* •Company raises full-year 2024 guidance NEW YORK, May 7, 2024 - Innovid Corp. ( |
|
May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Inn |
|
April 30, 2024 |
Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. |
|
April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
April 1, 2024 |
CTV / Innovid Corp. / Vintage Fund 5 Ltd. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SC 13G/A 1 ea0203062-13ga1vintag5innov.htm AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title |
|
March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi |
|
February 29, 2024 |
olicy for Recovery of Erroneously Award INNOVID CORP. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Innovid Corp. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of November 21, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11. 1. Persons Subject to Policy This Policy shall apply to |
|
February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Innovid Cor |
|
February 29, 2024 | ||
February 29, 2024 |
Employment Agreement between the Company and Dave Helmreich, dated December 13, 2022 11/2/2022 To: David Helmreich Offer of Employment Dear David Innovid, LLC. (“Innovid” or the "Company") is pleased to extend you this opportunity to work for the Company as Chief Commercial Officer. This letter sets forth information about the position that you are being offered at this time. Should you determine that you are interested in this position and would like to commence employment with t |
|
February 29, 2024 |
Employment Agreement between the Company and tNN0*L'S runc26,2012 T.i r.nr. Andr4ca ksFin inioLdrnnovi4.oo 534 gr.adway,suitc 1205, NY, Ny 1001? Te| 21t 965.7S55 r&r,in.ov d.os Rei otl€i., Em.lovn.nt 0e* Mt. Andreev-(aspri, hrovid li.. {the Conpany l 15 plci5.n 1o off€r yo! the sosition oi cont.olle., this letter embo.i.,::t. (erm5 of.!r alae. ot.mploym.nr lo you. As, a.ntroler Vou will repo* lo Mr. l:m!s Wenbc.s, ,. r!.h othet perJln rs rh! |
|
February 27, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
February 27, 2024 |
Innovid Reports Q4 and Fiscal Year 2023 Financial Results Innovid Reports Q4 and Fiscal Year 2023 Financial Results •Company exceeds both revenue and Adjusted EBITDA guidance for Q4 and full year 2023 •Q4 revenue grew to $38. |
|
February 5, 2024 |
Amended and Restated Bylaws of Innovid Corp. (a Delaware corporation) as of February 1, 2024 TABLE OF CONTENTS Page Article I - Corporate Offices 3 1.1 Registered Office 3 1.2 Other Offices 3 Article II - Meetings of Stockholders 3 2.1 Place of Meetings 3 2.2 Annual Meeting 3 2.3 Special Meeting 3 2.4 Notice of Business to be Brought Before a Meeting 4 2.5 Notice of Nominations for Election to the |
|
February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
November 30, 2023 |
INVESTOR DAY November 2023 DISCLAIMERS Forward-Looking Statements This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. |
|
November 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 30, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
November 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
November 8, 2023 |
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as ado |
|
November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
November 8, 2023 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a). Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Anthony Callini, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which |
|
November 8, 2023 |
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as ado |
|
November 8, 2023 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a). Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc |
|
November 8, 2023 |
Innovid Reports Q3 2023 Financial Results Innovid Reports Q3 2023 Financial Results •Q3 revenue increased to $36.2 million, up 5% year-over-year •CTV revenue from Ad Serving and Personalization, up 9% year-over-year •Company raises full year 2023 guidance NEW YORK, November 8, 2023 /PRNewswire/ - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform for delivery, personalization, and measurement of converged TV acr |
|
October 16, 2023 |
Employment Agreement between the Company and Anthony Callini, dated October 16, 2023 EXHIBIT 10.1 10/13/2023 To: Anthony Callini Offer of Employment Dear Anthony Innovid, LLC. (“Innovid” or the "Company") is pleased to extend to you this conditional offer of employment with the Company as Chief Financial Officer (CFO). This letter sets forth information about the position that you are being offered at this time. Should you determine that you are interested in this position and wou |
|
October 16, 2023 |
TRANSITION AGREEMENT, WAIVER, AND GENERAL RELEASE This TRANSITION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Tanya Andreev-Kaspin (hereinafter “Employee”) (each a “party” and collectively, the “parties”). |
|
October 16, 2023 |
Innovid Appoints New CFO and Announces Preliminary Unaudited Q3 2023 Revenue Exceeding Guidance •Preliminary Q3 Revenue of $36M, Above the High End of Guidance •Anthony Callini Named New Chief Financial Officer •Innovid to Release Third Quarter 2023 Results on Wednesday, November 8 NEW YORK, Oct. |
|
October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 16, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
September 14, 2023 |
As filed with the U.S. Securities and Exchange Commission on September 14, 2023 As filed with the U.S. Securities and Exchange Commission on September 14, 2023 Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdictio |
|
September 12, 2023 |
As filed with the U.S. Securities and Exchange Commission on September 12, 2023 As filed with the U.S. Securities and Exchange Commission on September 12, 2023 Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdictio |
|
August 8, 2023 |
Amended and Restated Non-Employee Director Compensation Program Innovid Corp. Amended and Restated Non-Employee Director Compensation Program (EFFECTIVE JUNE 6, 2023) Non-employee members of the board of directors (the “Board”) of Innovid, Corp. (the “Company”) shall receive cash and equity compensation as set forth in this Amended and Restated Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Progr |
|
August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi |
|
August 8, 2023 |
Innovid Reports Q2 2023 Financial Results Innovid Reports Q2 2023 Financial Results •Q2 revenue increased to $34.5 million, up 4% year-over-year •Q2 measurement revenue contributed $7.8 million, up 10% year-over-year, representing 23% of total Q2 revenue •Innovid raises full year 2023 revenue and Adjusted EBITDA* guidance NEW YORK, August 8, 2023 /PRNewswire/ - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform |
|
August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
August 8, 2023 |
FIRST LOAN MODIFICATION AGREEMENT This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of August 2, 2023, by and among (a) SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (SUCCESSOR BY PURCHASE TO THE FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BRIDGE BANK, N. |
|
July 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 2, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss |
|
July 6, 2023 |
Employment Agreement between the Company and Zvika Netter, dated July 2, 2023 Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) the type that the Registrant treats as private or confidential. |
|
July 5, 2023 |
Innovid Regains Compliance with NYSE Continued Listing Standards Innovid Regains Compliance with NYSE Continued Listing Standards NEW YORK, July 5, 2023 - Innovid Corp. |
|
July 5, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss |
|
June 8, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss |
|
May 19, 2023 |
As filed with the U.S. Securities and Exchange Commission on May 19, 2023 As filed with the U.S. Securities and Exchange Commission on May 19, 2023 Registration No. 333-261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other juris |
|
May 19, 2023 |
Innovid Receives NYSE Continued Listing Standards Notice Innovid Receives NYSE Continued Listing Standards Notice NEW YORK, May 19, 2023 – Innovid Corp. |
|
May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 19, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss |
|
May 17, 2023 |
CTV / Innovid Corp / ION Holdings 2, LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 INNOVID CORP. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679108 (CUSIP Number) May 16, 2023 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
May 17, 2023 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. |
|
May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi |
|
May 9, 2023 |
Innovid Reports Q1 2023 Financial Results Innovid Reports Q1 2023 Financial Results •Reports Q1 revenue increased to $30.5 million, up 18% year-over-year •Connected TV (CTV) accounted for 54% of video impressions in Q1 2023, vs. 49% in Q1 2022 NEW YORK, May 9, 2023 - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform for delivery, personalization, and measurement of converged TV across linear, connected TV (CTV) |
|
May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
May 9, 2023 |
424B3 1 a424b3resale.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 8 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capita |
|
May 9, 2023 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 7 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
April 26, 2023 | ||
April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
April 19, 2023 |
Experian Executive Joins Innovid Board of Directors Experian Executive Joins Innovid Board of Directors NEW YORK, April 19th, 2023 /PRNewswire/ – Innovid Corp. |
|
April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 19, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi |
|
April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 17, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi |
|
April 17, 2023 |
Innovid Announces Preliminary Unaudited First Quarter 2023 Revenue and Earnings Conference Call Date Innovid Announces Preliminary Unaudited First Quarter 2023 Revenue and Earnings Conference Call Date NEW YORK - April 17, 2023 - Innovid Corp. |
|
April 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or |
|
April 3, 2023 |
CTV / Innovid Corp / Vintage Fund 5 Ltd. - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679 108 (CUSIP Number) March 23, 2023 (Date of Ev |
|
March 29, 2023 |
CTV / Innovid Corp / GENESIS PARTNERS III LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Rece |
|
March 3, 2023 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 7 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
March 3, 2023 |
Innovid Corp. Form of Restricted Stock Unit Agreement INNOVID CORP. 2021 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”). The Company has granted to the participant listed below (“Participant”) |
|
March 3, 2023 |
cutive Change in Control Severance Plan Innovid, Inc. Executive Change in Control Severance Plan ARTICLE I. Establishment, Term, and Purpose 1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Change in Control Severance Plan (the “Plan”). 1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain em |
|
March 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Innovid Cor |
|
March 3, 2023 |
Innovid, Inc. Executive Severance Plan ARTICLE I. Establishment, Term, and Purpose 1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Severance Plan (the “Plan”). 1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain employees of the Company, its Subsidia |
|
March 3, 2023 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 6 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
March 3, 2023 |
Innovid Corp. Form of Stock Option Agreement INNOVID CORP. 2021 OMNIBUS INCENTIVE PLAN STOCK OPTION GRANT NOTICE Capitalized terms not specifically defined in this Stock Option Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”). The Company has granted to the participant listed below (“Participant”) the stock option d |
|
March 3, 2023 |
List of Subsidiaries of the Company Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2022 Name Jurisdiction of Incorporation Innovid LLC Delaware TV Squared Inc Delaware TV Squared Limited United Kingdom TV Squared GmbH Germany Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina |
|
February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
February 24, 2023 |
Innovid Reports Q4 and Fiscal Year 2022 Financial Results Innovid Reports Q4 and Fiscal Year 2022 Financial Results •Reports Q4 revenue grew to $33. |
|
February 9, 2023 |
Innovid Names Ken Markus Chief Operating Officer Google veteran to lead cross-functional, company-wide operations building increased value for customers through best-in-class services New York, NY – February 9, 2023 – Innovid Corp. |
|
February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
January 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com |
|
November 14, 2022 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a). Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Tanya Andreev-Kaspin, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w |
|
November 14, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 5 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
November 14, 2022 |
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted p |
|
November 14, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 6 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
November 14, 2022 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc |
|
November 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
November 14, 2022 |
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted p |
|
November 14, 2022 |
Exhibit 99.1 Innovid Reports Third Quarter 2022 Financial Results Increased revenue by 47% year-over-year to $34.5 million CTV accounted for 54% of the volume of all video impressions served TV measurement accounted for 23% of all revenue Generated net loss of $11.8 million and adjusted EBITDA* of $2.9 million, representing an 8% adjusted EBITDA margin* Innovid to host Investor Day on November 16, |
|
November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
October 19, 2022 |
CTV / Innovid Corp / Vintage Fund 5 Ltd. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SC 13G/A 1 ea166824-13ga1vintage5innov.htm AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title |
|
August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001 |
|
August 10, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 4 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
August 10, 2022 |
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursua |
|
August 10, 2022 |
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Agreement?) is dated as of the Effective Date between SILICON VALLEY BANK, a California corporation (?Bank?), and the borrowers listed on Schedule I hereto (?Borrower?). |
|
August 10, 2022 |
424B3 1 innovid424b3resales-1.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 5 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784 |
|
August 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 10, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm |
|
August 10, 2022 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a). Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Tanya Andreev-Kaspin, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w |
|
August 10, 2022 |
Exhibit 99.1 Innovid Reports Second Quarter 2022 Financial Results Delivered 45% year-over-year revenue growth to $33.1 million on an as-reported basis CTV accounted for 50% of the volume of all video impressions served TV measurement accounted for 22% of all revenue Launched InnovidXP ? the first cross-platform TV measurement solution powered by ad serving data and creative personalization NEW YO |
|
August 10, 2022 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc |
|
August 10, 2022 |
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursua |
|
July 8, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 4 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
July 8, 2022 |
Press Release dated July 8, 2022 by Innovid Corp. Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the ?Company?), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the ?Board?). Mr. Steven Cakebread has resigned for personal reasons and Mr. Brian H |
|
July 8, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 3 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
July 8, 2022 |
Press Release dated July 8, 2022 by Innovid Corp. EX-99.1 2 innovidannouncesachangeoni.htm EX-99.1 Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the “Company”), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the “Board”). Mr. Steven Cakebread |
|
July 8, 2022 |
Innovid Announces Changes to its Board of Directors Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the ?Company?), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the ?Board?). Mr. Steven Cakebread has resigned for personal reasons and Mr. Brian H |
|
July 8, 2022 |
8-K 1 innovid-8xkdirectorappoint.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 1, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction o |
|
June 9, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 2 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
June 9, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 3 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
June 8, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 8, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss |
|
May 10, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 2 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
May 10, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333- 264324 Prospectus Supplement No. 1 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supple |
|
May 9, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm |
|
May 9, 2022 |
424B3 1 innovidcorp-424b3resale.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 1 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated April 12, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784) |
|
May 9, 2022 |
EX-99.1 3 exhibit991-8xka.htm EX-99.1 Exhibit 99.1 REPORT OF INDEPENDENT AUDITOR Qualified Opinion We have audited the consolidated financial statements of TV Squared Limited (the Company), which comprise the Group Statements of Financial Position as of December 31, 2021, and the related Group Income Statement, Group Statement of Comprehensive Loss, Group Statement of Changes in Equity and Group S |
|
May 9, 2022 |
INNOVID CORP. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 INNOVID CORP. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On February 6, 2022, Innovid Corp. (?Innovid?) entered into a Stock Purchase Agreement with TV Squared Limited, a private company limited by shares incorporated under the laws of Scotland (?TV Squared?). On February 28, 2022 (the ?Acquisition Date?), Innovid completed the acquisition of all outstanding equity i |
|
May 9, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 1 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem |
|
May 6, 2022 |
Exhibit 99.1 Innovid Reports First Quarter 2022 Financial Results ?Successfully completed the acquisition of TVSquared to establish an independent solution for global cross-platform TV measurement ?Delivered 30% year-over-year revenue growth to $23.4 million excluding TVSquared and 44% year-over-year revenue growth to $25.9 million on an as-reported basis ?Grew CTV revenue, excluding TVSquared, by |
|
May 6, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi |
|
May 3, 2022 |
PROSPECTUS FOR 11,549,465 SHARES OF COMMON STOCK INNOVID CORP. 424B3 1 innovidtvsquared-424b3.htm 424B3 Filed Pursuant to Rule 425(b)(3) Registration No. 333-264324 PROSPECTUS FOR 11,549,465 SHARES OF COMMON STOCK OF INNOVID CORP. This prospectus relates to the resale from time to time of an aggregate of 11,549,465 shares of common stock, par value $0.0001 per share (the “common stock”), of Innovid Corp., a Delaware corporation (“Innovid”), issued in connecti |
|
April 29, 2022 |
Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 April 29, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Innovid Corp Registration Statement on Form S-1 Filed April 15, 2022 File No. 333-264324 To whom it may concern: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, |
|
April 28, 2022 |
As filed with the Securities and Exchange Commission on April 15, 2022. As filed with the Securities and Exchange Commission on April 15, 2022. Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdiction of incorporation or o |
|
April 27, 2022 | ||
April 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
April 15, 2022 |
As filed with the Securities and Exchange Commission on April 15, 2022. As filed with the Securities and Exchange Commission on April 15, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdiction of incorporation or organization) (Primary Sta |
|
April 15, 2022 |
Exhibit 107 CALCULATION OF REGISTRATION FEE FORM S-1 Innovid Corp. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit (1) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share 457(c) 11,549,465 $5.96 $68,834,811.40 .0000927 $6,380.99 T |
|
April 12, 2022 |
Filed Pursuant to Rule 424(b)(3) ?Registration No 333-261784 PROSPECTUS FOR 107,624,217 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS OF INNOVID CORP. |
|
March 25, 2022 |
As filed with the Securities and Exchange Commission on March 25, 2022. As filed with the Securities and Exchange Commission on March 25, 2022. Registration No. 333- 261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of i |
|
March 18, 2022 | ||
March 18, 2022 |
EX-4.4 3 a44descriptionofsecurities.htm EX-4.4 Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the capital stock of Innovid Corp. (“Innovid,” the “Company,” “we,” “us,” or “our”) and certain provisions of our amended and restated certificate of incorporation (the “Certifica |
|
March 18, 2022 | ||
March 18, 2022 |
Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2021 Name Jurisdiction of Incorporation Innovid Corp. Delaware Innovid LLC Delaware Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina |
|
March 18, 2022 |
Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 1 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe |
|
March 18, 2022 |
Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2021 Name Jurisdiction of Incorporation Innovid Corp. Delaware Innovid LLC Delaware Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina |
|
March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-400 |
|
March 18, 2022 |
EX-4.4 3 a44descriptionofsecurities.htm EX-4.4 Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the capital stock of Innovid Corp. (“Innovid,” the “Company,” “we,” “us,” or “our”) and certain provisions of our amended and restated certificate of incorporation (the “Certifica |
|
March 3, 2022 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
March 3, 2022 |
Innovid Completes TVSquared Acquisition, Establishing Global Independent Measurement Platform for Linear, CTV & Digital Acquisition Expected to Expand Global Market Opportunity and Contribute to Accelerated Revenue Growth in 2022 NEW YORK, NY, March 3, 2022 ? Innovid (NYSE: CTV), a leading independent connected TV (CTV) advertising delivery and measurement platform, has completed its previously announced acquisition of TVSquared, an independent global measurement and attribution platform for converged TV. |
|
February 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co |
|
February 24, 2022 |
EX-99.1 2 a991innovidfy21financialsp.htm EX-99.1 Innovid Reports Q4 and Fiscal Year 2021 Financial Results •Increased revenue by 31% year-over-year, driven by growth in CTV plus increased adoption of personalization •Grew CTV revenue by 48% year-over-year •CTV accounted for 45% of total 2021 revenue, up from 40% in 2020 •Achieved adjusted EBITDA* of $5.4 million reflecting 110% growth year-over-ye |
|
February 7, 2022 |
8-K 1 innovid-8xk.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorpora |
|
February 7, 2022 |
Innovid Announces Acquisition of Converged TV Measurement Leader, TVSquared Combination Expands Independent, Currency-Grade Measurement Platform Across TV, CTV & Digital ?Purchase price valued at approximately $160 million consists of $100 million in cash as well as additional stock consideration. |
|
February 7, 2022 |
STOCK PURCHASE AGREEMENT by and among TV SQUARED LIMITED THE SECURITY HOLDERS OF THE COMPANY SET FORTH ON ANNEX I HERETO SHAREHOLDER REPRESENTATIVE SERVICES LLC, AS SECURITY HOLDERS REPRESENTATIVE and INNOVID CORP. |
|
February 7, 2022 |
Innovid Provides Preliminary Q4 & Full Year 2021 Financial Results Update Management will Hold a Conference Call to Discuss Q4 and Full Year 2021 Financial Results on February 24 at 8:30 a. |
|
February 4, 2022 |
As filed with the United States Securities and Exchange Commission on February 4, 2022. As filed with the United States Securities and Exchange Commission on February 4, 2022. |
|
February 4, 2022 |
Global Share Incentive Plan (2008). INNOVID, Inc. Global Share Incentive Plan (2008) Fifth Amended and Restated on October 22, 2020 1. Name And Purpose 1.1 This plan as amended from time to time, originally established and adopted by the Board of Directors of the Company, Innovid, Inc. on September 25, 2008 and approved and adopted by the unanimous written consent of the stockholders effected October 4, 2008, and was amended and res |
|
February 4, 2022 |
CALCULATION OF REGISTRATION FEE FORM S-8 Innovid Corp. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Innovid Corp. 2021 Omnibus Incentive Plan Common Stock, par value $0.0001 per share 457(c) and 457(h) 40,000,000 (2) |
|
December 30, 2021 |
CTV / Innovid Corp / Vintage Fund 5 Ltd. - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679 108 (CUSIP Number) November 30, 2021 (Date of |
|
December 30, 2021 |
Filed Pursuant to Rule 424(b)(3) ?Registration No 333-261784 PROSPECTUS FOR 108,549,444 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS OF INNOVID CORP. |
|
December 29, 2021 |
As filed with the Securities and Exchange Commission on December 29, 2021. As filed with the Securities and Exchange Commission on December 29, 2021. Registration No. 333- 261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of incorporation |
|
December 29, 2021 |
Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 CORRESP 1 filename1.htm Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 December 29, 2021 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Innovid Corp. Registration Statement on Form S-1 Filed December 20, 2021 File No. 333-261784 To whom it may concern: Pursuant to Rule 461(a) under the Secur |
|
December 29, 2021 |
Exhibit 99.1 INDEX TO FINANCIAL STATEMENT Audited Financial Statement for Innovid Corp. (F/K/A ION Acquisition Corp 2 Ltd.) : Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of February 16, 2021(as restated) F-3 Notes to Financial Statement (as restated) F-4 F-1 Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A Tel-Aviv 6492102, Israel Tel: +972-3-6 |
|
December 29, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 16, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 333-252440 87-3769599 (State or other jurisdiction (Commission File Number) (I.R.S. E |
|
December 21, 2021 |
List of Subsidiaries of the Company Exhibit 21.1 Subsidiaries of Innovid Corp. Name of Subsidiary Jurisdiction of Organization Innovid LLC Delaware |
|
December 21, 2021 |
As filed with the Securities and Exchange Commission on December 20, 2021. As filed with the Securities and Exchange Commission on December 20, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of incorporation or organization) (Primary |
|
December 20, 2021 |
CTV / Innovid Corp / ION Holdings 2, LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 INNOVID CORP. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679108 (CUSIP Number) December 31, 2021 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this |
|
December 10, 2021 |
CTV / Innovid Corp / SEQUOIA CAPITAL ISRAEL IV, L.P. - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 457 |
|
December 10, 2021 |
CTV / Innovid Corp / GENESIS PARTNERS III LP - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Receive Notice |
|
December 10, 2021 |
CTV / Innovid Corp / Netter Zvika - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Receive Notice |
|
December 6, 2021 |
Exhibit 10.7 Innovid Corp. Non-Employee Director Compensation Program Non-employee members of the board of directors (the ?Board?) of Innovid, Inc. (the ?Company?) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this ?Program?). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatical |
|
December 6, 2021 |
List of Subsidiaries of the Company. Exhibit 21.1 Subsidiaries of Innovid Corp. Name of Subsidiary Jurisdiction of Organization Innovid LLC Delaware |
|
December 6, 2021 |
Exhibit 4.1 NUMBER SHARES C- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP INNOVID CORP. COMMON STOCK THIS CERTIFIES THAT is the owner of common stock, par value $0.0001 per share (each, a ?Common Stock?), of Innovid Corp., a Delaware corporation (the ?Company?), transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This |
|
December 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40048 (Commission File Number) 87-37 |
|
December 6, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction: On June 24, 2021, ION Acquisition Corp 2 Ltd., a Cayman Islands exempted company (?ION?), entered into an Agreement and Plan of Merger (the ?Merger Agreement?) with Inspire Merger Sub 1, Inc., a Delaware corporation and a direct, wholly owned subsidiary of ION (?Merger Sub 1?). The following unaudited pro forma |
|
December 6, 2021 |
Exhibit 10.8 INDEMNIFICATION AND ADVANCEMENT AGREEMENT This Indemnification and Advancement Agreement (?Agreement?) is made as of , 2021 by and between Innovid Corp., a Delaware corporation (the ?Company?), and , [a member of the Board of Directors] [an officer] of the Company (?Indemnitee?). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee |
|
December 6, 2021 |
Exhibit 10.2 Execution Version INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this ?Agreement?), dated as of November 30, 2021, is made and entered into by and among: (1)Innovid Corp., a Delaware corporation (the ?Company?), which was formerly named ION Acquisition Corp 2 Ltd. (?ION?); (2)certain equityholders of ION listed on Schedule A hereto ( the ?SPAC Holders?); and (3)certain form |
|
December 6, 2021 |
Exhibit 4.2 [Form of Warrant Certificate] [FACE] Number [ ] Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW INNOVID CORP. Incorporated Under the Laws of the State of Delaware CUSIP [ ] Warrant Certificate This certifies that [ ], or registered assigns, is the registered holder of [ ] warrants |
|
December 6, 2021 |
Exhibit 3.2 Amended and Restated Bylaws of Innovid Corp. (a Delaware corporation) TABLE OF CONTENTS Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought Before a Meeting 1 2.5 Notice of Nominations for Election to the Board 5 2. |
|
December 6, 2021 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ION ACQUISITION CORP 2 ION Acquisition Corp 2 (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1.The name of the Corporation is ION Acquisition Corp 2. The Corporation was incorporated under the name ION Acquisition Corp |
|
December 6, 2021 |
Exhibit 99.1 INNOVID, INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except stock and per stock data) September 30, 2021 December 31, 2020 (Unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 14,472 $ 15,645 Trade receivables, net (allowance for doubtful accounts of $83 and $121 at September 30, 2021 and December 31, 2020, respectively) 34,223 34,804 Prepa |
|
December 6, 2021 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF INNOVID Exhibit 99.3 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF INNOVID The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and audited financials statements and related notes of Innovid either included in the final prospectus and definitive proxy statement/prospectus (the ?Proxy?) relating to t |
|
December 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation) (Commission File Nu |
|
December 1, 2021 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 13, 2021, pursuant to the provisions of Rule 12d2-2 (a). |
|
December 1, 2021 |
Innovid Begins Trading on New York Stock Exchange Under Symbol “CTV” Exhibit 99.1 Innovid Begins Trading on New York Stock Exchange Under Symbol ?CTV? ?Global leader in Connected TV ad delivery and measurement begins trading today as Innovid, under the new ticker symbol ?CTV? ?The transaction generated approximately $251 million of proceeds including financing anchored by top-tier institutional investors ?Global brands and agencies tap Innovid as the independent le |
|
November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2021 ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Delaware 001-40048 N/A (State or other jurisdiction of incorporation) (Commission |
|
November 30, 2021 |
IACB Shareholders Vote to Approve the Proposed Business Combination with Innovid Exhibit 99.1 IACB Shareholders Vote to Approve the Proposed Business Combination with Innovid NEW YORK, NY ? November 29, 2021 - ION Acquisition Corp 2, Ltd. (?ION?) (NYSE:IACB), a special purpose acquisition company, announced today that its shareholders voted to approve the previously announced business combination with Innovid Inc. (?Innovid? or the ?Company?), a leading independent connected T |
|
November 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 00 |
|
November 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 26, 2021 (November 25, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of i |
|
November 17, 2021 |
ION Announces Innovid’s Financial Results for the Nine Months Ended September 30, 2021 Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. (File No. 001-40048) ION Announces Innovid?s Financial Results for the Nine Months Ended September 30, 2021 ?Revenue of $64.3 million is up 41% over last year, driven by 65% growth |
|
November 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 17, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi |
|
November 17, 2021 |
ION Announces Innovid’s Financial Results for the Nine Months Ended September 30, 2021 Exhibit 99.1 ION Announces Innovid?s Financial Results for the Nine Months Ended September 30, 2021 ? Revenue of $64.3 million is up 41% over last year, driven by 65% growth in revenue from CTV ? Adjusted EBITDA of $3.7 million surges 201% vs. one year ago, representing a 6% adjusted EBITDA margin ? Expected to start trading as Innovid, under the new ticker symbol ?CTV? on December 1, 2021, after |
|
November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40048 ION ACQUISIT |
|
November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi |
|
November 10, 2021 |
Exhibit 99.1 ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination ? Special meeting of ION Acquisition Corp 2 Ltd.?s stockholders to approve the proposed business combination with Innovid, Inc. to be held on November 29, 2021 New York, NY ? November 10, 2021 ? ION Acquisition Corp 2 Ltd. (NYSE: IAC |
|
November 10, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi |
|
November 10, 2021 |
EX-99.1 2 ea150363ex99-1ionacq2.htm PRESS RELEASE, DATED AS OF NOVEMBER 10, 2021 Exhibit 99.1 ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination ● Special meeting of ION Acquisition Corp 2 Ltd.’s stockholders to approve the proposed business combination with Innovid, Inc. to be held on November 2 |
|
November 10, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-258472 PROXY STATEMENT FOR EXTRAORDINARY GENERAL MEETING OF ION ACQUISITION CORP 2 LTD. (A CAYMAN ISLANDS EXEMPTED COMPANY) PROSPECTUS FOR 124,880,615 SHARES OF COMMON STOCK AND 10,222,500 WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF ION ACQUISITION CORP 2 LTD. (TO BE RENAMED ?INNOVID CORP.? FOLLOWING DOMESTICATION IN THE STATE OF DELAWARE AN |
|
November 8, 2021 |
ION Acquisition Corp. 2 Ltd. 89 Medinat Hayehudim Street Herzliya 5676672, Israel CORRESP 1 filename1.htm ION Acquisition Corp. 2 Ltd. 89 Medinat Hayehudim Street Herzliya 5676672, Israel November 8, 2021 VIA EDGAR Division of Corporation Finance Office of Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: ION Acquisition Corp. 2, Ltd. Amendment No. 3 to Registration Statement on Form S-4 Filed November 5, 2021 File No. 333-258472 Ladies an |
|
November 5, 2021 |
Consent of Steven Cakebread to be Named as a Director. Exhibit 99.6 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp |
|
November 5, 2021 |
As filed with the United States Securities and Exchange Commission on November 5, 2021. |
|
November 5, 2021 |
Consent of Jonathan Saacks to be Named as a Director. Exhibit 99.5 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp |
|
November 5, 2021 |
Consent of Rachel Lam to be Named as a Director. Exhibit 99.3 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp |
|
November 5, 2021 |
Consent of Michael DiPiano to be Named as a Director. Exhibit 99.4 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp |
|
November 5, 2021 |
CORRESP 1 filename1.htm November 5, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.C. 20549 Attn: Rebekah Lindsey, Senior Staff Accountant Christine Dietz, Accounting Branch Chief Mitchell Austin, Staff Attorney Jan Woo, Legal Branch Chief Re: ION Acquisition Corp 2 Ltd. Amendment No. 2 to Registra |
|
October 25, 2021 |
Form of Preliminary Proxy Card. Exhibit 99.1 slide1 ION Acquisition Corp 2 LTD. (?ION?) THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON [ ], Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the proxy statement/prospectus, dated [ ], to which this Proxy is attached, or in the Merger Agreement (as defined below). The |
|
October 25, 2021 |
As filed with the United States Securities and Exchange Commission on October 25, 2021. |
|
October 25, 2021 |
October 25, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D. |
|
October 25, 2021 |
425 1 ea149288-425ionacquisit2.htm FORM 425 Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No. 001-40048 This filing relates to the proposed merger involving ION Acquisition Corp. 2 Ltd. (“ION”) with Innovid, Inc |
|
October 25, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to 425 1 ea149289-425ionacq2.htm FORM 425 Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 This filing relates to the proposed merger involving ION Acquisition Corp. 2 Ltd. (“ION”) with Innovid, Inc. (“ |
|
October 20, 2021 |
EX-99.1 2 ea148996ex99-1ionacq2.htm PRESS RELEASE, DATED OCTOBER 20, 2021 Exhibit 99.1 Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support New York - October 20, 2021 - Innovid, a leading independent connected TV (CTV) advertising delivery and measurement platform, and ION Acquisition Corp. 2 L |
|
October 20, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 The SPAC frenzy has cooled. But adtech company Innovid just got a $50 million vote of confidence in its deal to go public. Ryan Joe Just now innovid ? |
|
October 20, 2021 |
Exhibit 99.1 Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support New York - October 20, 2021 - Innovid, a leading independent connected TV (CTV) advertising delivery and measurement platform, and ION Acquisition Corp. 2 Ltd. (?ION?) (NYSE:IACB), a special purpose acquisition company, today anno |
|
October 20, 2021 |
425 1 ea148996-8kionacq2.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 20, 2021 (October 18, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 333-2 |
|
October 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 20, 2021 (October 18, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 333-252440 N/A (State or other jurisdiction of in |
|
October 19, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript of an interview that took place at Citi 2021 Global Technology Virtual Conference with Zvika Netter, CEO and Co-founder of Innovid, Inc., |
|
October 19, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript from a presentation given at the Jefferies Israel Innovation Summit by Zvika Netter, CEO and Co-founder of Innovid, Inc., on September 30 |
|
October 19, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript of an interview that took place at the Piper Sandler Global Technology Conference TechTok with Zvika Netter, CEO and Co-founder of Innovi |
|
October 6, 2021 |
As filed with the United States Securities and Exchange Commission on October 5, 2021. |
|
October 5, 2021 |
October 5, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D. |
|
September 2, 2021 |
Filed by ION Acquisition Corp 2 Ltd. pursuant to Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 The following is an excerpt from a presentation given by Innovid, Inc. Chief Executive Officer Zvika Netter to potential investors on August 15, 2021. |